Bioactive Glass Market

The market for Bioactive Glass was estimated at $685 million in 2025; it is anticipated to increase to $979 million by 2030, with projections indicating growth to around $1.40 billion by 2035.

Report ID:DS1801293

Author:Debadatta Patel - Senior Consultant

Published Date:June 2025

Datatree

Life Science

Medical Device

Bioactive Glass

Customization Available

Bioactive Glass - 2025-2035

Market Outlook
Market Key Insights
Growth Opportunity
Market Dynamics
Application
Recent Development
Impact Analysis

Report Summary

Market Data

Methodology

Table of Contents

Report Summary

Market Data

Methodology

Table of Contents

Global Bioactive Glass Market Outlook

Revenue, 2025

$685M

Forecast, 2035

$1.40B

CAGR, 2026 - 2035

7.4%

The Bioactive Glass industry revenue is expected to be around $685.2 million in 2026 and expected to showcase growth with 7.4% CAGR between 2026 and 2035. On top of this outlook, the Bioactive Glass market is gaining ground within high end biomaterials and regenerative therapies, as usage climbs in key medical applications and implant technologies. Pressure builds due to rising cases of musculoskeletal and dental conditions, along with more orthopedic operations and dental implant treatments taking place. Clinicians often choose materials that stimulate bone healing and help patients move faster after treatment. New funding patterns in research and development pair with better payment rules for fresh orthobiologic tools, while movement toward less invasive procedures adds another layer of support. These trends together elevate the position of Bioactive Glass within major healthcare networks worldwide. One key reason orthopedics and dentistry grab so much attention? They make up nearly 81% of how this material gets used. This points straight to its central place in shaping today’s most advanced fixes for bones and teeth

When bioactive glass is used as a biomaterial it gives rise to stable chemical bonds with both bone and soft tissue, the material itself is based on silicate networks. Its surface is highly reactive and this combined with the controlled release of ions results in superior osteostimulation and osseointegration when compared to the materials used in conventional medicine. Bioactive glass holds the lead position in the market by virtue of its product silicate, this segment generating sales worth $443.32 million in the year 2025. This is due to its performance in applications such as bone void fillers, synthetic bone grafts, dental implants and spinal fusion devices. These applications include orthopaedics, dentistry, the reconstruction of facial bones and tissue engineering. Silica based bioactive glass is used increasingly as a framework material and for the bioactive surface coating of metal implants to improve their long term stability and biocompatibility. Bioactive glass is increasingly being utilised in 3D printing for bespoke implants, added to composite materials for such uses where loads are borne and its use is found in wound healing and drug delivery systems. As Bioactive Glass has developed these technologies they have been able to increase the potential market, improve the medical research and make their product a basis for future treatments restoring tissues and organs.

Bioactive Glass market outlook with forecast trends, drivers, opportunities, supply chain, and competition 2025-2035 — Bioactive Glass Market Outlook

Market Key Insights

Right now, the Bioactive Glass industry sits at $685.2 million in 2025. It will stretch toward $1.40 billion by 2035. Growth happens because people want it more each year. Seven point 4% yearly advance drives that shift forward. Users include those fixing bones with implants, caring for teeth, healing wounds.
Pioneering companies, including SCHOTT AG, Mo Sci and BonAlive Biomaterials, are responsible for the markets competitive landscape.
The United States and Germany will lead the bioactive glass market and are expected to have growth rates ranging from 4.8% to 7.1% from 2025 to 2030.
The highest growth rates, with a Compound Annual Growth Rate of between 8.5 and 10.2% , are expected to be observed in emerging markets such as South Africa, India and Brazil.
Firms such as Transition’s Pioneering Medical Solutions could boost Bioactive Glass market value to $79 million by 2030.
Over the period between 2025 and 2035, the Bioactive Glass market is predicted to grow by $714 million. This expansion is likely to be driven by dentistry and tissue engineering applications which will command a larger share of the market.
Bioactive glass used in orthopaedics is poised to grow at a compound annual growth rate of 104% between the years 2025 and 2035, primarily due to growing interest in orthopaedics and significant advancements in dental surgery techniques.

Bioactive Glass - Country Share Analysis

Opportunities in the Bioactive Glass

Japans population is also aging at a rapid rate and is now turning to treatments that make use of regenerative orthopaedic and dental solutions which integrate well with bone. In 2025, silicate bioactive glass generated a revenue of $443.32 million and is anticipated to expand to $624.70 million by 2030 with an estimated compound annual growth rate of 7.1% between 2026 and 2030. 3D printing and new products should increase the demand for silicate bioactive glass. In the Asia Pacific and Western European hospital networks and clinics, orthopaedic and dental applications in silicate based materials will experience the most growth.

Growth Opportunities in North America and Europe

A fresh wave of interest in Bioactive Glass shows up most clearly within North American orthopedics, where older patients combined with rising numbers of injuries push clinicians toward solutions that stimulate bone repair and support long term tissue growth. Instead of old methods, many now turn toward engineered materials built to handle heavy stress while filling gaps left by fractures or disease. Spinal procedures benefit just as much, using layered composites treated with active glass compounds to strengthen recovery outcomes. What sets these apart is their ability to adapt without losing scientific backing, earning them space alongside established treatments due to proven value across medical spending reviews. Fighting harder for share are long standing makers of medical devices alongside smaller players focused only on raw substances, so showing unique results in trials, preparing surgeons through targeted learning paths, and weaving Bioactive Glass into current equipment designs becomes essential for moving forward. One more thing tissue engineering scaffolds might see gains, especially with stronger ties to hospitals and research institutions helping prove their worth and get approvals faster. At the same time, tools for handling long term wounds could also move forward under these collaborative arrangements.

A spread of Bioactive Glass across Europe stands clearest in dental applications driven by active demand in implant placement, tissue regeneration, and repair solutions, along with practitioner familiarity and governance that prefers established ceramic formulations. What opens new paths? In clinic bone grafts using Bioactive Glass, its blending into toughened restorative mixes, or active surface layers on implants, each tied to lasting results, lower chances of infection, stronger bone bonding. Pressure comes from focused makers of medical materials and local providers catering to local clinics; staying ahead means offering products approved by European authorities, fitting smoothly into digital practice rhythms, working closely with influential experts shaping outcomes in facial and gum treatments. What pushes the market forward? Tissue engineering, along with better wound care tools. These help manage long term injuries, giving firms room to fund trials and prove value. That effort pays off, especially when accessing top tier medical infrastructures across Europe.

Market Dynamics and Supply Chain

Driver: Increasing Demand in Orthopedics, and Rising Popularity in Cosmeceuticals

The increasing popularity of glass in orthopedics is also mainly due to its excellent compatibility with the human body and its capacity to connect effectively with various tissues. Both hard and soft ones alike. Primarily used in items such, as bone graft substitutes the utilization of bioactive glass is also greatly contributing to market expansion within the field. It is also anticipated that market growth will also continue to rise as more innovations and studies are also conducted in the realm of treatment. The cosmeceutical industry is also another emerging segment showing interest in bioactive glass because of its outstanding skin regeneration and antimicrobial properties. Its increasingly incorporated into skincare and topical wound healing products, predicting a steady growth trajectory for the bioactive glass market within this niche.

The dental industry sees a demand for bioactive glass because it has also shown success in treating periodontal disease and tooth sensitivity as well as in performing dental bone graft procedures. The growth of dental surgery techniques, alongside the proven benefits of using glass in these treatments is also expected to drive market growth.

Restraint: High Production Costs

The production of Bioactive Glass requires steps and sophisticated technology which makes the total cost high due to expensive raw materials and advanced methods used in the process This results in higher market prices which can pose challenges for consumers affordability especially in developing countries The increased prices might cause a drop in demand, for Bioactive Glass affecting market trends and growth adversely.

Opportunity: Integration of phosphate bioactive glass into sustainable European premium skincare and cosmetics targeting eco-conscious consumers and Adoption of borate bioactive glass wound dressings for diabetic patients in United States and India

There is a growing trend among European premium skincare companies in favour of mineral derived actives that are environmentally friendly. These mineral derived actives need to be shown to work well while complying with clean beauty requirements. Concentrations of biologically active glass powders are known to provide a mild, active skin exfoliant along with the controlled release of the ions calcium and phosphate which are vital in repair of the skins outer layer. However, they have seen limited use in standard skincare products. Phosphate containing products will be worth $118.9 million in 2030. The worth of such products was $83.59 million in 2025 and will rise at a compound annual growth rate of 7.3%. Cosmetics such as face masks, creams and serums in Europe will be the products to show the greatest growth.

Increasing prevalence of diabetes, in the US and India, has generated a requirement for anti infection wound dressings that also hasten the healing process. Although there are various bioactive glasses that liberate ions in a controlled fashion, these substances stimulate the formation of new blood vessels, have inherent antibacterial properties and are not only fully utilised in any hospital settings. Borates globally will expand at a rate of 8.27% with an annual growth value of USD 235.53 million by the year 2030 from an estimated USD 158.28 million in the year 2025. The wound care dressings and composite foams industries will be the largest sector.

Challenge: Regulatory Challenges

Bioactive Glass, primarily used in the medical field for applications such as bone and tissue regeneration, falls under stringent regulations and requires approval from authorities like the FDA. The rigorous approval processes, coupled with mandatory clinical trials, often result in delays in product launches. It also escalates the overall expenditure, again contributing to the hefty pricing situation. These regulatory hurdles can present a significant impediment to the rapid growth of the Bioactive Glass market.

Supply Chain Landscape

Raw Materials Processing

SCHOTT AGMo Sci Corporation

Bioactive Glass Manufacturing

BonAlive Biomaterials Ltd.NovaBoneNoraker

Medical Device Integration

SCHOTT AGNovaBoneNoraker

End-Use Applications

Orthopedic ImplantsDental Bone GraftsTissue Engineering

Raw Materials Processing

SCHOTT AGMo Sci Corporation

Bioactive Glass Manufacturing

BonAlive Biomaterials Ltd.NovaBoneNoraker

Medical Device Integration

SCHOTT AGNovaBoneNoraker

End-Use Applications

Orthopedic ImplantsDental Bone GraftsTissue Engineering

Bioactive Glass - Supply Chain

Use Cases of Bioactive Glass in Orthopedic Implants & Wound Healing

Orthopedic Implants : In the field of orthopedics, nano-sized bioactive glass is especially important. Its ability to promote bone regeneration makes it an essential component of orthopedic implants. Its chemically active surface forms a bond with bone tissues, facilitating the bodys natural healing process. Companies like NovaBone and Bioglass stand out in this segment with their pioneering work in bioactive glass technologies for orthopedic applications.

Dental Care : Serving as a crucial player in dental care, bioactive glass is predominantly used in tooth fillings and periodontal treatment. Its high bioactivity helps prevent tooth decay and promote tooth remineralization. The market leader, Mo-Sci Corporation, offers bespoke solutions using bioactive glass technology, promoting better oral health.

Wound Healing : Bioactive glass is also a revolutionary material in wound treatments. Its antibacterial properties and ability to stimulate skin regeneration make it an irreplaceable tool in wound healing practices. Promogran and Arobella Medical are key players, pushing the boundaries of wound care treatment with bioactive glass.

Recent Developments

Bioactive Glass, a key player in the biomedical sector, has seen a recent surge in popularity due to its unique properties and diverse applications. Primarily utilized in tissue engineering and bone graft substitutes, Bioactive Glass is known for its excellent biocompatibility and ability to facilitate the bodys natural healing process.

December 2024 : Johnson & Johnson introduced an advanced Bioactive Glass implant system, JNJ-BioG, for tackling bone loss issues in orthopedic surgeries

October 2024 : Corning Incorporated unveiled the next generation of Corning Bioactive Glass compositions, fortified to promote rapid wound healing and tissue regeneration

August 2024 : 3M launched a novel Bioactive Glass formula, 3M TheraGlass, in the dental consumables market, offering superior anti-microbial properties and enhanced oral health solutions.

Impact of Industry Transitions on the Bioactive Glass Market

As a core segment of the Medical Device industry, the Bioactive Glass market develops in line with broader industry shifts. Over recent years, transitions such as Pioneering Medical Solutions and Green Manufacturings Embrace have redefined priorities across the Medical Device sector, influencing how the Bioactive Glass market evolves in terms of demand, applications and competitive dynamics. These transitions highlight the structural changes shaping long-term growth opportunities.

Pioneering Medical Solutions

The rapid development of innovative medical products is driving interest in bioactive glass in region's such as dentistry and orthopaedics, where the biocompatibility of this material has considerable implications for bone grafts and dental implants. The benefits of bioactive glass, in terms of enhanced host tissue integration, the reduction of potential risks of infection and support for minimally invasive surgery, are rendering it a more favourable option than other biomaterials in the fields of tissue engineering and regenerative medicine. This improvement not only only raises the standard of care and speeds up surgical procedures but is expected to contribute approximately $79 million to the growth of the bioactive glass industry by 2030. Bioactive glass is proving to be a strong platform material which supports long term medical device performance and accelerates the healing process. It is thus now being incorporated into next generation implants and restorative products.

Green Manufacturings Embrace

When companies look for greener choices, they often find them in Bioactive Glass a material that performs well while minimizing harm. Its low energy process makes production more sustainable, cutting down power needs and pollution output. Take the glass sector, where this material helps create insulation that keeps buildings cooler in summer and warmer in winter. That shift leads to steadier energy use across offices, houses, and urban spaces. So its clear how Bioactive Glass supports shifting toward greener living without harming the planet.